Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (271-280 of 770) with videos related to

Pageof 77
Sort By:
American Heart Journal|October 18, 2008
Determining the most appropriate components for a composite clinical trial outcomeM Angelyn Bethel, Rury Holman, Steven M Haffner, et al.
Clinical Biochemistry|September 10, 2013
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndromeKai M Eggers, Paul W Armstrong, Robert M Califf, et al.
European Journal of Heart Failure|August 28, 2007
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trialVic Hasselblad, Wendy Gattis Stough, Monica R Shah, et al.
American Heart Journal|August 17, 2004
Cardiovascular disease and chronic kidney disease: insights and an updatePatricia J M Best, Donal N Reddan, Peter B Berger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2012
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIRJula K Inrig, Shelly Sapp, Huiman Barnhart, et al.
Health Affairs (Project Hope)|January 8, 2019
Seven Former FDA Commissioners: The FDA Should Be An Independent Federal AgencyRobert M Califf, Margaret Hamburg, Jane E Henney, et al.
The American Journal of Medicine|February 15, 2003
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trialLeslie Cho, Deepak L Bhatt, Steve P Marso, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 8, 2006
Where's the flap?John Heitner, Mat Lotfi, J Kevin Harrison, et al.
American Heart Journal|May 4, 2010
ST2 and mortality in non-ST-segment elevation acute coronary syndromeKai M Eggers, Paul W Armstrong, Robert M Califf, et al.
Journal of the American College of Cardiology|December 12, 2002
Integrating quality into the cycle of therapeutic developmentRobert M Califf, Eric D Peterson, Raymond J Gibbons, et al.
Pageof 77

Showing results (271-280 of 770) with videos related to

Sort By:
Pageof 77
American Heart Journal|October 18, 2008
Determining the most appropriate components for a composite clinical trial outcomeM Angelyn Bethel, Rury Holman, Steven M Haffner, et al.
Clinical Biochemistry|September 10, 2013
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndromeKai M Eggers, Paul W Armstrong, Robert M Califf, et al.
European Journal of Heart Failure|August 28, 2007
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trialVic Hasselblad, Wendy Gattis Stough, Monica R Shah, et al.
American Heart Journal|August 17, 2004
Cardiovascular disease and chronic kidney disease: insights and an updatePatricia J M Best, Donal N Reddan, Peter B Berger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2012
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIRJula K Inrig, Shelly Sapp, Huiman Barnhart, et al.
Health Affairs (Project Hope)|January 8, 2019
Seven Former FDA Commissioners: The FDA Should Be An Independent Federal AgencyRobert M Califf, Margaret Hamburg, Jane E Henney, et al.
The American Journal of Medicine|February 15, 2003
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trialLeslie Cho, Deepak L Bhatt, Steve P Marso, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 8, 2006
Where's the flap?John Heitner, Mat Lotfi, J Kevin Harrison, et al.
American Heart Journal|May 4, 2010
ST2 and mortality in non-ST-segment elevation acute coronary syndromeKai M Eggers, Paul W Armstrong, Robert M Califf, et al.
Journal of the American College of Cardiology|December 12, 2002
Integrating quality into the cycle of therapeutic developmentRobert M Califf, Eric D Peterson, Raymond J Gibbons, et al.
Pageof 77